Reports
Sale
Global Cell-Based Assays Market Size, Share, Trends, Forecast: By Product and Services: Products, Services; By Application: Drug Discovery, Basic Research, Predictive Technology, ADME Studies, Others; By Assay Type: Cell Viability Assay, Cytotoxicity Assay, Others; By End User; Regional Analysis; Supplier Landscape; 2024-2032
Global Cell-Based Assays Market Size
The global cell-based assays market was valued at USD 8,677.43 million in 2023, driven by the increasing incidence of chronic diseases, such as cancer, diabetes, and cardiovascular diseases across the globe. The market is expected to grow at a CAGR of 14% during the forecast period of 2024-2032, with the values likely to reach USD 28,220.80 million by 2032.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Global Cell-Based Assays Market Outlook
- The demand for cell-based assay is increasing, owing to the innovations in cell-based assay technologies, such as high-throughput screening (HTS) and 3D cell culture systems.
- One of the major market trends is the increasing investments in drug discovery and development by pharmaceutical and biotechnology companies, thereby, boosting the demand for cell-based assays.
- The cytotoxicity assay segment is experiencing significant growth driven by the shift towards personalized medicine, which requires precise and targeted therapies.
Global Cell-Based Assays Market Overview
Cell-based assays are laboratory procedures used to measure the biological activity of substances on living cells. These assays evaluate various cellular functions, including cell proliferation, cytotoxicity, cell signaling, and gene expression, to understand the effects of drugs, chemicals, or other biological agents on cell behavior. The cell-based assays are essential tools in modern biomedical research, offering critical insights into cellular functions and the potential effects of therapeutic interventions.
The market is witnessing growth in investment for drug discovery and development by pharmaceutical and biotechnology companies. This is boosting the demand for cell-based assays. This trend is expected to continue, owing to the increasing viability of this approach, the convenience it provides, and the growing number of chronic diseases such as cancer, diabetes, and cardiovascular diseases. Rising incidence of such conditions is driving the need for new and effective therapies, thereby propelling the demand for cell-based assays.
Global Cell-Based Assays Market Growth Drivers
Rising Technological Advancements is Augmenting Market Growth
Recent advancements in technology are a significant driver of the cell-based assays market. Technological advancements in cell-based assay technologies, such as high-throughput screening (HTS) and 3D cell culture systems, have significantly improved the efficiency and accuracy of these assays. For instance, a leading biotech firm named InSphero launched a revolutionary 3D cell culture platform in July 2020. This technology provided more physiologically relevant data, thereby, enhancing the accuracy of drug screening processes and enabling more precise modeling of disease conditions. The adoption of such cutting-edge technologies is expected to significantly boost the market growth.
Rising Focus on Personalized Medicine
The growing emphasis on personalized medicine is another key driver of the cell-based assays market. Personalized medicine requires the development of therapies tailored to individual patient profiles, which often involves extensive use of cell-based assays to understand patient-specific cellular responses to various treatments. For instance, in April 2024, Roche has significantly increased its investment in personalized medicine research, leveraging cell-based assays to develop more precise and effective therapies. This initiative aims to enhance patient outcomes by using cell-based assays to identify the most suitable treatment options based on individual cellular responses, thereby driving the demand for these assays in the market.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Global Cell-Based Assays Market Trends
The market is witnessing several trends and developments to improve the current global scenario. Some of the notable trends are as follows:
| Trends | Impact |
| Growing Drug Discovery Activities | Increasing investments in drug discovery and development by pharmaceutical and biotechnology companies is boosting the demand for cell-based assays. |
| Government and Private Funding | Substantial funding from government bodies and private organizations for research and development activities in the life sciences sector is supporting the growth of the cell-based assays market. |
| Expansion of Biopharmaceutical | Industry The rapid growth of the biopharmaceutical industry, particularly in emerging markets, is leading to increased use of cell-based assays for drug screening and development. |
| Adoption of 3D Cell Cultures | The growing adoption of 3D cell cultures, which provide a more physiologically relevant environment for cell-based assays, is enhancing the accuracy of results and driving market growth. |
Global Cell-Based Assays Market Segmentation
Market Breakup by Product and Services
- Products
- Instruments
- Software
- Consumables
- Microplates
- Probes & Labels
- Assay Kits
- Cell Lines
- Reagents
- Others
- Services
Market Breakup by Application
- Drug Discovery
- Basic Research
- Predictive Technology
- ADME Studies
- Others
Market Breakup by Assay Type
- Cell Viability Assay
- Cytotoxicity Assay
- Cell Death Assay
- Cell Proliferation Assay
- Others
Market Breakup by End User
- Pharmaceutical and Biotechnology Companies
- Academic and Government Research Institutes
- Contract Research Organizations (CROs)
- Others
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Global Cell-Based Assays Market Share
Market Segmentation Based on Product and Services is Anticipated to Witness Substantial Growth
Based on products, the market report offers an insight into instruments, software, and consumables. Since cell-based assays are increasingly used in the healthcare sector for patient diagnosis and drug development activities, the instrument segment is experiencing significant growth. It can be attributed to its efficacy in toxicology studies for safety assessment of drugs and chemicals, further contributing to market expansion. The use of cell-based assays in these activities helps in understanding the cellular responses to new compounds, identifying target interactions, and optimizing lead compounds, ultimately accelerating the drug development timeline. Along with products, services also hold a notable market share. The market has been witnessing a trend of outsourcing services to leverage expertise at a reasonable price.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Global Cell-Based Assays Market Analysis by Region
Based on the region, the market covers North America, Europe, Asia Pacific, Latin America, as well as the Middle East and Africa. North America is dominating the market share due to rising burden of chronic diseases in the aging population, as well as the presence of an advanced healthcare infrastructure. Further, the increasing technological advancements in cell-based assays, heightened awareness surrounding better diagnostic procedures, and the surge in the adoption of cell-based assay for better results are some of the factors supporting the market growth.
Europe also holds a notable cell-based assays market share driven by increasing investments in healthcare technologies and greater access to advanced medical devices. Additionally, Asia Pacific is expected to witness substantial market growth fueled by the growing patient pool and the rising recognition of cell-based assay benefits. Increased government initiatives to improve healthcare services and the rising disposable income is poised to boost the region’s market share.
Leading Players in the Global Cell-Based Assays Market
The key features of the market report include patents analysis and strategic initiatives which constitutes funding and investment analysis, partnerships, and collaborations analysis by the key players. The major companies in the market are as follows:
Merck KGaA
Merck KGaA, headquartered in Darmstadt, Germany, is a leading science and technology company operating in the healthcare, life sciences, and performance materials sectors. Merck KGaA is actively involved in the cell-based assays market. The company's life sciences division, through its brands such as Sigma-Aldrich and Millipore, offers advanced cell-based assay technologies, including high-throughput screening platforms, 3D cell culture systems, and specialized reagents.
Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc., headquartered in Waltham, Massachusetts, USA, operates in various sectors, including life sciences, analytical instruments, specialty diagnostics, and laboratory products and services. It has wide range of cell-based assays in the market, offering a comprehensive portfolio of products and solutions designed to meet the needs of researchers and clinicians. The company provides advanced cell-based assay technologies, including high-throughput screening (HTS) systems, reagents, assay kits, and cell culture products.
Other key players in the market include Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Lonza Group Ltd., PerkinElmer, Inc., Promega Corporation, Charles River Laboratories International, Inc., Eurofins DiscoverX, and Cell Biolabs, Inc., among others.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product and Services |
|
| Breakup by Application |
|
| Breakup by Assay Type |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Key Questions Answered in the Global Cell-Based Assays Market Report
- What was the global cell-based assays market value in 2023?
- What is the global cell-based assays market forecast outlook for 2024-2032?
- What are the regional markets covered in the EMR report?
- What is market segmentation based on application?
- What is the market segmentation based on products and services?
- What are the major end users in the market?
- What is the market segmentation based on assay types?
- What are the major factors aiding the global cell-based assays market demand?
- How has the market performed so far and how is it anticipated to perform in the coming years?
- What are the major market trends influencing the market?
- What are the market's major drivers, opportunities, and restraints?
- Which regional market is expected to lead the market share in the forecast period?
- Which country is estimated to witness expedited growth during the forecast period?
- How does the rise in the chronic diseases impacting the market size?
- How do the technological innovations in cell-based assay affect the market landscape?
- Which application area is expected to have a high market value in the coming years?
- Who are the key players involved in the cell-based assays market?
- What are the current unmet needs and challenges in the market?
- How are partnerships, collaborations, mergers and acquisitions among the key market players shaping the market dynamics?
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Cell-Based Assays Market Overview
3.1 Global Cell-Based Assays Market Historical Value (2017-2023)
3.2 Global Cell-Based Assays Market Forecast Value (2024-2032)
4 Vendor Positioning Analysis
4.1 Key Vendors
4.2 Prospective Leaders
4.3 Niche Leaders
4.4 Disruptors
5 Global Cell-Based Assays Market Landscape*
5.1 Global Cell-based Assays: Developers Landscape
5.1.1 Analysis by Year of Establishment
5.1.2 Analysis by Company Size
5.1.3 Analysis by Region
5.2 Global Cell-based Assays: Product Landscape
5.2.1 Analysis by Product
5.2.2 Analysis by Services
6 Global Cell-Based Assays Market Dynamics
6.1 Market Drivers and Constraints
6.2 SWOT Analysis
6.2.1 Strengths
6.2.2 Weaknesses
6.2.3 Opportunities
6.2.4 Threats
6.3 PESTEL Analysis
6.3.1 Political
6.3.2 Environmental
6.3.3 Social
6.3.4 Technological
6.3.5 Ethical
6.3.6 Legal
6.4 Porter’s Five Forces Model
6.4.1 Bargaining Power of Suppliers
6.4.2 Bargaining Power of Buyers
6.4.3 Threat of New Entrants
6.4.4 Threat of Substitutes
6.4.5 Degree of Rivalry
6.5 Key Demand Indicators
6.6 Key Price Indicators
6.7 Industry Events, Initiatives, and Trends
6.8 Value Chain Analysis
7 Global Cell-Based Assays Market Segmentation (2017-2032)
7.1 Global Cell-Based Assays Market (2017-2032) by Product and Services
7.1.1 Market Overview
7.1.2 Products
7.1.2.1 Instruments
7.1.2.2 Software
7.1.2.3 Consumables
7.1.2.3.1 Microplates
7.1.2.3.2 Probes & Labels
7.1.2.3.3 Assay Kits
7.1.2.3.4 Cell Lines
7.1.2.3.5 Reagents
7.1.2.3.6 Others
7.1.3 Services
7.2 Global Cell-Based Assays Market (2017-2032) by Application
7.2.1 Market Overview
7.2.2 Drug Discovery
7.2.3 Basic Research
7.2.4 Predictive Technology
7.2.5 ADME Studies
7.2.6 Others
7.3 Global Cell-Based Assays Market (2017-2032) by Assay Type
7.3.1 Market Overview
7.3.2 Cell Viability Assay
7.3.3 Cytotoxicity Assay
7.3.4 Cell Death Assay
7.3.5 Cell Proliferation Assay
7.3.6 Others
7.4 Global Cell-Based Assays Market (2017-2032) by End User
7.4.1 Market Overview
7.4.2 Pharmaceutical and Biotechnology Companies
7.4.3 Academic and Government Research Institutes
7.4.4 Contract Research Organizations (CROs)
7.4.5 Others
7.5 Global Cell-Based Assays Market (2017-2032) by Region
7.5.1 Market Overview
7.5.2 North America
7.5.3 Europe
7.5.4 Asia Pacific
7.5.5 Latin America
7.5.6 Middle East and Africa
8 North America Cell-Based Assays Market (2017-2032)
8.1 North America Cell-Based Assays Market (2017-2032) by Product and Services
8.1.1 Market Overview
8.1.2 Products
8.1.2.1 Instruments
8.1.2.2 Software
8.1.2.3 Consumables
8.1.2.3.1 Microplates
8.1.2.3.2 Probes & Labels
8.1.2.3.3 Assay Kits
8.1.2.3.4 Cell Lines
8.1.2.3.5 Reagents
8.1.2.3.6 Others
8.1.3 Services
8.2 North America Cell-Based Assays Market (2017-2032) by Application
8.2.1 Market Overview
8.2.2 Drug Discovery
8.2.3 Basic Research
8.2.4 Predictive Technology
8.2.5 ADME Studies
8.2.6 Others
8.3 North America Cell-Based Assays Market (2017-2032) by Country
8.3.1 United States of America
8.3.2 Canada
9 Europe Cell-Based Assays Market (2017-2032)
9.1 Europe Cell-Based Assays Market (2017-2032) by Product and Services
9.1.1 Products
9.1.1.1 Instruments
9.1.1.2 Software
9.1.1.3 Consumables
9.1.1.3.1 Microplates
9.1.1.3.2 Probes & Labels
9.1.1.3.3 Assay Kits
9.1.1.3.4 Cell Lines
9.1.1.3.5 Reagents
9.1.1.3.6 Others
9.1.2 Services
9.2 Services Europe Cell-Based Assays Market (2017-2032) by Application
9.2.1 Market Overview
9.2.2 Drug Discovery
9.2.3 Basic Research
9.2.4 Predictive Technology
9.2.5 ADME Studies
9.2.6 Others
9.3 Europe Cell-Based Assays Market (2017-2032) by Country
9.3.1 United Kingdom
9.3.2 Germany
9.3.3 France
9.3.4 Italy
9.3.5 Others
10 Asia Pacific Cell-Based Assays Market (2017-2032)
10.1 Asia Pacific Cell-Based Assays Market (2017-2032) by Product and Services
10.1.1 Market Overview
10.1.2 Products
10.1.2.1 Instruments
10.1.2.2 Software
10.1.2.3 Consumables
10.1.2.3.1 Microplates
10.1.2.3.2 Probes & Labels
10.1.2.3.3 Assay Kits
10.1.2.3.4 Cell Lines
10.1.2.3.5 Reagents
10.1.2.3.6 Others
10.1.3 Services
10.2 Asia Pacific Cell-Based Assays Market (2017-2032) by Application
10.2.1 Market Overview
10.2.2 Drug Discovery
10.2.3 Basic Research
10.2.4 Predictive Technology
10.2.5 ADME Studies
10.2.6 Others
10.3 Asia Pacific Cell-Based Assays Market (2017-2032) by Country
10.3.1 China
10.3.2 Japan
10.3.3 India
10.3.4 ASEAN
10.3.5 Australia
10.3.6 Others
11 Latin America Cell-Based Assays Market (2017-2032)
11.1 Latin America Cell-Based Assays Market (2017-2032) by Product and Services
11.1.1 Market Overview
11.1.2 Products
11.1.2.1 Instruments
11.1.2.2 Software
11.1.2.3 Consumables
11.1.2.3.1 Microplates
11.1.2.3.2 Probes & Labels
11.1.2.3.3 Assay Kits
11.1.2.3.4 Cell Lines
11.1.2.3.5 Reagents
11.1.2.3.6 Others
11.1.3 Services
11.2 Latin America Cell-Based Assays Market (2017-2032) by Application
11.2.1 Market Overview
11.2.2 Drug Discovery
11.2.3 Basic Research
11.2.4 Predictive Technology
11.2.5 ADME Studies
11.2.6 Others
11.3 Latin America Cell-Based Assays Market (2017-2032) by Country
11.3.1 Brazil
11.3.2 Argentina
11.3.3 Mexico
11.3.4 Others
12 Middle East and Africa Cell-Based Assays Market (2017-2032)
12.1 Middle East and Africa Cell-Based Assays Market (2017-2032) by Product and Services
12.1.1 Market Overview
12.1.2 Products
12.1.2.1 Instruments
12.1.2.2 Software
12.1.2.3 Consumables
12.1.2.3.1 Microplates
12.1.2.3.2 Probes & Labels
12.1.2.3.3 Assay Kits
12.1.2.3.4 Cell Lines
12.1.2.3.5 Reagents
12.1.2.3.6 Others
12.1.3 Services
12.2 Middle East and Africa Cell-Based Assays Market (2017-2032) by Application
12.2.1 Market Overview
12.2.2 Drug Discovery
12.2.3 Basic Research
12.2.4 Predictive Technology
12.2.5 ADME Studies
12.2.6 Others
12.3 Middle East and Africa Cell-Based Assays Market (2017-2032) by Country
12.3.1 Saudi Arabia
12.3.2 United Arab Emirates
12.3.3 Nigeria
12.3.4 South Africa
12.3.5 Others
13 Regulatory Framework
13.1 Regulatory Overview
13.2 US FDA
13.3 EU EMA
13.4 INDIA CDSCO
13.5 JAPAN PMDA
13.6 Others
14 Patent Analysis
14.1 Analysis by Type of Patent
14.2 Analysis by Publication Year
14.3 Analysis by Issuing Authority
14.4 Analysis by Patent Age
14.5 Analysis by CPC Analysis
14.6 Analysis by Patent Valuation
14.7 Analysis by Key Players
15 Strategic Initiatives
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership and Collaborations
15.3 Analysis by Joint Ventures
15.4 Analysis by Leading Players
15.5 Analysis by Geography
16 Supplier Landscape
16.1 Market Share Analysis, By Region (Top 5 Companies)
16.1.1 Market Share Analysis: Global
16.1.2 Market Share Analysis: North America
16.1.3 Market Share Analysis: Europe
16.1.4 Market Share Analysis: Asia-Pacific
16.1.5 Market Share Analysis: Others
16.2 Merck KGaA
16.2.1 Financial Analysis
16.2.2 Product Portfolio
16.2.3 Demographic Reach and Achievements
16.2.4 Mergers and Acquisitions
16.2.5 Certifications
16.3 Becton, Dickinson and Company
16.3.1 Financial Analysis
16.3.2 Product Portfolio
16.3.3 Demographic Reach and Achievements
16.3.4 Mergers and Acquisitions
16.3.5 Certifications
16.4 Bio-Rad Laboratories, Inc.
16.4.1 Financial Analysis
16.4.2 Product Portfolio
16.4.3 Demographic Reach and Achievements
16.4.4 Mergers and Acquisitions
16.4.5 Certifications
16.5 Lonza Group Ltd .
16.5.1 Financial Analysis
16.5.2 Product Portfolio
16.5.3 Demographic Reach and Achievements
16.5.4 Mergers and Acquisitions
16.5.5 Certifications
16.6 PerkinElmer, Inc .
16.6.1 Financial Analysis
16.6.2 Product Portfolio
16.6.3 Demographic Reach and Achievements
16.6.4 Mergers and Acquisitions
16.6.5 Certifications
16.7 Promega Corporation
16.7.1 Financial Analysis
16.7.2 Product Portfolio
16.7.3 Demographic Reach and Achievements
16.7.4 Mergers and Acquisitions
16.7.5 Certifications
16.8 Thermo Fisher Scientific Inc .
16.8.1 Financial Analysis
16.8.2 Product Portfolio
16.8.3 Demographic Reach and Achievements
16.8.4 Mergers and Acquisitions
16.8.5 Certifications
16.9 Charles River Laboratories International, Inc.
16.9.1 Financial Analysis
16.9.2 Product Portfolio
16.9.3 Demographic Reach and Achievements
16.9.4 Mergers and Acquisitions
16.9.5 Certifications
16.10 Eurofins DiscoverX
16.10.1 Financial Analysis
16.10.2 Product Portfolio
16.10.3 Demographic Reach and Achievements
16.10.4 Mergers and Acquisitions
16.10.5 Certifications
16.11 Cell Biolabs, Inc .
16.11.1 Financial Analysis
16.11.2 Product Portfolio
16.11.3 Demographic Reach and Achievements
16.11.4 Mergers and Acquisitions
16.11.5 Certifications
17 Global Cell-Based Assays Market – Distribution Model (Additional Insight)
17.1 Overview
17.2 Potential Distributors
17.3 Key Parameters for Distribution Partner Assessment
18 Key Opinion Leaders (KOL) Insights (Additional Insight)
*Additional insights provided are customisable as per client requirements.
* The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible.
**The supplier list is not exhaustive. Moreover, we can provide analysis of companies as per custom requests.
Purchase Options 10% off
Call us
Purchase Full Report
Datasheet
$ 2969
$2699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 5499
$4999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 6599
$5999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 7699
$6999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER